Age-Related Lymphocyte Output During Disease-Modifying Therapies for Multiple Sclerosis

Background Patients with multiple sclerosis exhibit the same qualitative and quantitative changes in immune system cells observed in aging. In the last 20 years, multiple sclerosis patients have shown an increase in life expectancy and average age, but clinical trial inclusion criteria typically exc...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Drugs & aging 2020-10, Vol.37 (10), p.739-746
Hauptverfasser:	Paghera, Simone, Sottini, Alessandra, Previcini, Vanessa, Capra, Ruggero, Imberti, Luisa
Format:	Artikel
Sprache:	eng
Schlagworte:	Age Age Factors Aged Aging Autoimmune diseases B-Lymphocytes - cytology B-Lymphocytes - drug effects B-Lymphocytes - immunology Biomarkers Bone marrow Bone Marrow - drug effects Bone Marrow - immunology Cell division Clinical trials Disease Female Geriatrics/Gerontology Humans Immune system Immunosenescence - drug effects Immunosenescence - genetics Immunosuppressive Agents - therapeutic use Internal Medicine Lymphocytes Male Medicine Medicine & Public Health Monoclonal antibodies Multiple sclerosis Multiple Sclerosis - drug therapy Multiple Sclerosis - immunology Original Research Article Patients Pharmacology/Toxicology Pharmacotherapy Receptors, Antigen, T-Cell - genetics Receptors, Antigen, T-Cell - immunology Recombination, Genetic Statistical analysis T-Lymphocytes - cytology T-Lymphocytes - drug effects T-Lymphocytes - immunology Thymus gland Thymus Gland - drug effects Thymus Gland - immunology Variables
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!